Advertisement

National HIV/AIDS Case Management

  • Zunyou WuEmail author
  • Yurong Mao
  • Jennifer M. McGoogan
Chapter

Abstract

China’s approach to HIV case management has evolved from little to none before the “Four Frees and One Care” policy was issued in 2004 to a complex two-stage system whereby people with diagnosed HIV infection were managed differently depending on whether they were or were not eligible for antiretroviral therapy (ART). Those in the pre-ART period were followed by local epidemiologists, while those who had initiated ART were followed by ART doctors. Unfortunately, many PLWH were lost to follow-up in the pre-ART period. However, after CD4 count-based ART eligibility requirements were abolished in 2016, HIV case management could be integrated into ART service delivery. This evolution reflects China’s consistent, pragmatic approach to evidence-based policymaking that allows new findings and innovative strategies to be quickly adopted in order to benefit as many PLWH as possible.

References

  1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.  https://doi.org/10.1056/NEJMoa1105243.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Gu D, Mao Y, Tang Z, Montaner J, Shen Z, Zhu Q, et al. Loss to follow-up from HIV screening to ART initiation in rural China. PLoS One. 2016;11(10):e016346.  https://doi.org/10.1371/journal.pone.0164346.CrossRefGoogle Scholar
  3. He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013;8(11):e77981.  https://doi.org/10.1371/journal.pone.0077981.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Ministry of Health Working Group on Clinical AIDS Treatment. China free antiretroviral therapy manual. 3rd ed. Beijing: People’s Medical Publishing House; 2012. [in Chinese].Google Scholar
  5. National Center for AIDS/STD Control and Prevention. 2008 National HIV/AIDS prevention and treatment implementation report and plan for 2009. National Provincial AIDS Directors Meeting. Beijing: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; 2009.Google Scholar
  6. National Center for AIDS/STD Control and Prevention. 2017 National HIV/STD/HCV prevention and treatment implementation report. National Provincial AIDS Directors Meeting. Ningbo: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention; 2018.Google Scholar
  7. Pisani E, Wu Z. HIV in China: 30 years in numbers. In: Wu Z, editor. HIV/AIDS in China—beyond the numbers. Singapore: People’s Medical Publishing House; 2017. p. 150–73.Google Scholar
  8. Wang N, Wang L, Wu Z, Guo W, Sun X, Poundstone K, et al. Estimating the number of people living with HIV/AIDS in China: 2003–09. Int J Epidemiol. 2010;39(Suppl 2):ii21–8.  https://doi.org/10.1093/ije/dyq209.CrossRefPubMedPubMedCentralGoogle Scholar
  9. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection—recommendations for a public health approach. Geneva: World Health Organization; 2016. http://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 1 Oct 2018.Google Scholar
  10. Wu Z, Sun X, Sullivan SG, Detels R. Public health. HIV testing in China. Science. 2006;312(5779):1475–6.  https://doi.org/10.1126/science.1120682.CrossRefPubMedGoogle Scholar
  11. Wu Z, Zhao Y, Ge X, Mao Y, Tang Z, Shi CX, et al. Simplified HIV testing and treatment in China: analysis of mortality rates before and after a structural intervention. PLoS Med. 2015;12(9):e1001874.  https://doi.org/10.1371/journal.pmed.1001874.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Wu Z, Pisani E, Chaddah A. Finding those at risk, China’s way. In: Wu Z, editor. HIV/AIDS in China—beyond the numbers. Singapore: People’s Medical Publishing House; 2017. p. 49–60.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.NCAIDSChina CDCBeijingChina

Personalised recommendations